Literature DB >> 11514916

Pyoderma gangrenosum.

N M Blitz1, D Rudikoff.   

Abstract

Pyoderma gangrenosum (PG) is an idiopathic, painful and destructive condition that usually presents as an ulceration on the pretibial region of the legs. It primarily affects patients with inflammatory bowel disease, arthritis, myeloproliferative disorders and chronic hepatitis, and occasionally affects patients with other conditions, but it may also occur without any associated illness. Since there are no specific serologic or histologic markers for PG, it must be diagnosed clinically. Treatment usually involves immunosuppressant therapy as well as treatment of the underlying disease. The course of PG is unpredictable, and prognosis depends on the extent of the skin lesions at the time of diagnosis, underscoring the need for early and aggressive management.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11514916

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  10 in total

1.  Systemic lupus erythematosus presenting as pyoderma gangrenosum in two cases.

Authors:  Seval Pehlevan Masatlioğlu; Fatih Göktay; Ayşe Tülin Mansur; Ayşe Deniz Akkaya; Pembegül Güneş
Journal:  Rheumatol Int       Date:  2008-11-29       Impact factor: 2.631

2.  Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Authors:  Claudio Marasca; Giuseppina Fontanella; Maria C Annunziata; Dario Marasca; Gabriella Fabbrocini
Journal:  Int Wound J       Date:  2019-04-01       Impact factor: 3.315

Review 3.  [Pyoderma gangrenosum].

Authors:  K Herberger
Journal:  Hautarzt       Date:  2016-09       Impact factor: 0.751

4.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

5.  Tracheobronchial pulmonary disease associated with pyoderma gangrenosum.

Authors:  Soichiro Kanoh; Hideo Kobayashi; Ken Sato; Kazuo Motoyoshi; Shinsuke Aida
Journal:  Mayo Clin Proc       Date:  2009-06       Impact factor: 7.616

6.  Pyoderma gangrenosum: A case report of bilateral dorsal hand lesions and literature review of management.

Authors:  Donald S Mowlds; Jeff J Kim; Patrick Murphy; Garrett A Wirth
Journal:  Can J Plast Surg       Date:  2013

Review 7.  Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.

Authors:  A P Ruhl; J E Ganz; S J Bickston
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487

8.  Skin manifestations of inflammatory bowel disease.

Authors:  Brian L Huang; Stephanie Chandra; David Quan Shih
Journal:  Front Physiol       Date:  2012-02-06       Impact factor: 4.566

Review 9.  Autoimmunity against type VII collagen in inflammatory bowel disease.

Authors:  Gheorghe Hundorfean; Markus F Neurath; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2010-10       Impact factor: 5.310

10.  Incisional pyoderma gangrenosum after caesarean section: Two case reports.

Authors:  Tsuyoshi Murata; Hyo Kyozuka; Toma Fukuda; Tsuyoshi Hiraiwa; Akiko Yamaguchi; Keiya Fujimori
Journal:  Case Rep Womens Health       Date:  2019-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.